Eczema Study

Clinics: Greater Manchester, Lancashire, Merseyside, South Staffordshire, South Yorkshire, Teesside and West Yorkshire

Therapy Area: Eczema

Gender and Age: Males & Females aged 18 – 65

Reimbursement: £2700 plus reasonable travel

Eczema clinical trial at MAC

About The Research...

MAC Clinical Research is currently conducting a trial to test a new oral medication for eczema, also known as atopic dermatitis. Eczema is one of the most common types of skin diseases and affects about 10% of adults. Common features of this inflammatory skin disease include itching and dryness. Eczema often relapses, meaning symptoms will improve for a while but then return.

The purpose of this trial is to test how well the trial drug works at improving eczema, and to see how safe and well tolerated it is. During the trial, eligible participants will receive the trial drug or placebo (dummy medication). Participants will attend a total of 12 visits, including outpatient visits and telephone calls at one of our clinics over a period of approximately 14 weeks.

A full description of the study will be given before you decide to take part, both over the phone and during an appointment at a MAC clinic. This will include you receiving the full patient information sheet (PIS).

Clinics: Greater Manchester, Lancashire, Merseyside, South Staffordshire, South Yorkshire, Teesside and West Yorkshire

Reimbursement:  £2700 plus reasonable travel

Criteria

Key Inclusion Criteria:

  • Male or female aged 18 – 65.
  • Diagnosis of plaque eczema for at least the past 6 months.
  • BMI 18 – 35 kg/m2.

 

Key Exclusion Criteria:

  • Use of Methotrexate, Steroids, cyclophosphamide, or phototherapy within 4 weeks of screening.
  • Continued use of topical agents, including corticosteroids, other than approved emollients that could affect their atopic dermatitis within 2 weeks prior to study dosing.
  • Use of anti-inflammatory medications, such as ibuprofen, during the trial.
  • History of serious infection within the past 6 weeks of screening.

 

Other eligibility criteria will apply. Please contact MAC for more information.

Any other information

Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the participants’ treating physician.

MAC Clinical Research is conducting a trial to evaluate a potential new treatment for eczema.

If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • Hidden
  • (You can enter any supporting information here)
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
Data Privacy Statement

Know someone who may be interested in taking part? Share this page here:

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on email
Email